Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
High-Pressure Ion Chromatography System Delivers New Levels of Simplicity and Flexibility
Friday, February 05, 2016
Thermo Scientific Dionex Integrion High-Pressure Ion Chromatography (HPIC) system breaks new ground in productivity and efficiency for environmental, food safety, pharmaceutical and industrial/petrochemical laboratories.
Unwrapping New Year trends at Pharmapack Europe
Wednesday, January 20, 2016
Serialization, combination products, emerging markets, outsourcing, TVF and adherence identified as the key themes in drug delivery and packaging for 2016.
Two years on NanoSight is Reaping the Benefits of Joining Malvern Instruments
Friday, December 11, 2015
The latest software release along with an expansion of the global technical specialist team, highlight Malvern Instruments’ ongoing commitment to extending and supporting the application of NanoSight, a nanoparticle characterization technology with unique capabilities.
Science of Synthesis 4.2 by Thieme Chemistry Released
Friday, November 13, 2015
SOS 4.2 released with over 2,400 printed pages of new content.
Biotage Introduces Isolera™ Assist
Tuesday, October 27, 2015
A new simple to use flash purification interface.
CPhI: SCHOTT Expands Delamination Control
Friday, October 16, 2015
First large vial that keeps delamination under control paves the way for pharma manufacturers warding off the risk of product recalls.
Quotient Clinical showcases Translational Pharmaceutics and RapidFACT at AAPS 2015
Wednesday, October 14, 2015
Quotient Clinical will be highlighting the benefits of its unique, integrated approach to formulation development, real-time adaptive manufacturing and clinical testing on booth 1662 at this year’s AAPS Annual Meeting and Exposition.
Mettler Toledo Announces Product Innovations
Tuesday, October 13, 2015
Mettler Toledo is launching a series of intelligent upgrades to its world-renowned weighing and dosing portfolio aimed at saving time and increasing lab productivity in keeping with lean laboratory principles.
New Tools for Biopharma Development
Friday, October 02, 2015
New tools from Malvern that answer to specific analytical challenges in biopharma development will take center stage at this year’s AAPS Annual Meeting and Exposition, in Orlando, USA (Orange County Convention Center, 25 - 29 October 2015).
Showing Results 1 - 10 of 1313
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,900+ scientific and medical posters
4,200+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!